Analysis of SM4 sulfatide as a P-selectin ligand using model membranes

Biophysical Chemistry

Volumn 150, Issue 1-3, 2010, Pages 98-104

  Simonis, Dirk ^a   Schlesinger, Martin ^a   Seelandt, Christian ^b   Borsig, Lubor ^b   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Glycolipid; Metastasis; Quartz crystal microbalance (QCM); Selectin; Sulfatide; Tumor cell adhesion

Indexed keywords

3 SULFATED GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE; HEPARIN; LIQUEMIN N; NADROPARIN; PADGEM PROTEIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; LIPOSOME; PROTEIN BINDING; SULFATIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE MICROSCOPY; LIGAND BINDING; LIPID ANALYSIS; LIPID RAFT; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; CARCINOMA; CELL MEMBRANE; CHEMISTRY; COLON TUMOR; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; GALACTOSYLCERAMIDES; HEPARIN; LIPOSOMES; MEMBRANE MICRODOMAINS; MICE; P-SELECTIN; PROTEIN BINDING; SULFOGLYCOSPHINGOLIPIDS;

EID: 77953696001     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2010.01.007     Document Type: Article

References (38)

1. Aguirre-Ghiso J.A. Models, mechanisms and clinical evidence of cancer dormancy. Nat. Rev. Cancer 2007, 7:834-846.
2. Vestweber D., Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 1999, 79:181-213.
3. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287.
4. Borsig L. The role of platelet activation in tumor metastasis. Expert Rev. Anticancer Ther. 2008, 8:1247-1255.
5. Kim Y.J., Borsig L., Han H.L., Varki N.M., Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am. J. Pathol. 1999, 115:461-472.
6. Kannagi R., Izawa M., Koike T., Miyazaki K., Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004, 95:377-384.
7. Sato M., Narita T., Kimura N., Zenita K., Hashimoto T., Manabe T., Kannagi R. The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells. Anticancer Res. 1997, 17:3505-3511.
8. Orntoft T.F., Vestergaard E.M. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999, 20:362-371.
9. Morichika H., Hamanaka Y., Tai T., Ishizuka I. Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 1996, 78:43-47.
10. Makhlouf A.M., Fathalla M.M., Zakhary M.A., Makarem M.H. Sulfatides in ovarian tumors: clinicopathological correlates. Int. J. Gynecol. Cancer 2004, 14:89-93.
11. Kobayashi T., Honke K., Kuramitsu Y., Hosokawa M., Miyazaki T., Murata J., Saiki I., Ishizuka I., Makita A. Cell-surface sulfoglycolipids are involved in the attachment of renal-cancer cells to laminin. Int. J. Cancer 1994, 56:281-285.
12. Zhong Wu X., Honke K., Long Zhang Y., Liang Zha X., Taniguchi N. Lactosylsulfatide expression in hepatocellular carcinoma cells enhances cell adhesion to vitronectin and intrahepatic metastasis in nude mice. Int. J. Cancer 2004, 110:504-510.
13. Aruffo A., Kolanus W., Walz G., Fredman P., Seed B. CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell 1991, 67:35-44.
14. Suzuki Y., Toda Y., Tamatani T., Watanabe T., Suzuki T., Nakao T., Murase K., Kiso M., Hasegawa A., Tadano-Aritomi K., et al. Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1). Binding epitope in sulfated sugar chain. Biochem. Biophys. Res. Commun. 1993, 190:426-434.
15. Bajorath J., Hollenbaugh D., King G., Harte W., Eustice D.C., Darveau R.P., Aruffo A. CD62/P-selectin binding sites for myeloid cells and sulfatides are overlapping. Biochemistry 1994, 33:1332-1339.
16. Merten M., Thiagarajan P. Role of sulfatides in platelet aggregation. Circulation 2001, 104:2955-2960.
17. Garcia J., Callewaert N., Borsig L. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells. Glycobiology 2007, 17:185-196.
18. Beauharnois M.E., Lindquist K.C., Marathe D., Vanderslice P., Xia J., Matta K.L., Neelamegham S. Affinity and kinetics of sialyl-Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Biochemistry 2005, 44:9507-9519.
19. Gege C., Vogel J., Bendas G., Rothe U., Schmidt R.R. Synthesis of the Sialyl Lewis X epitope attached to glycolipids with different core structures and their selectin-binding characteristics in a dynamic test system. Chemistry 2000, 6:111-122.
20. Weerachatyanukul W., Probodh I., Kongmanas K., Tanphaichitr N., Johnston L.J. Visualizing the localization of sulfoglycolipids in lipid raft domains in model membranes and sperm membrane extracts. Biochim. Biophys. Acta 2007, 1768:299-310.
21. Kakkar A.K., Levine M.N., Kadziola Z., Lemoine N.R., Low V., Patel H.K., Rustin G., Thomas M., Quigley M., Williamson R.C. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J. Clin. Oncol. 2004, 22:1944-1948.
22. Lee A.Y., Rickles F.R., Julian J.A., Gent M., Baker R.I., Bowden C., Kakkar A.K., Prins M., Levine M.N. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J. Clin. Oncol. 2005, 23:2123-2129.
23. Klerk C.P., Smorenburg S.M., Otten H.M., Lensing A.W., Prins M.H., Piovella F., Prandoni P., Bos M.M., Richel D.J., van Tienhoven G., Buller H.R. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J. Clin. Oncol. 2005, 23:2130-2135.
24. Hostettler N., Naggi A., Torri G., Ishai-Michaeli R., Casu B., Vlodavsky I., Borsig L. P-selectin and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. FASEB J. 2007, 21:3562-3572.
25. Läubli H., Stevenson J.L., Varki A., Varki N.M., Borsig L. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest. Cancer Res. 2006, 66:1536-1542.
26. Ludwig R.J., Boehme B., Podda M., Henschler R., Jager E., Tandi C., Boehncke W.H., Zollner T.M., Kaufmann R., Gille J. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res. 2004, 64:2743-2750.
27. Simonis D., Christ K., Alban S., Bendas G. Affinity and kinetics of different heparins binding to P- and L-selectin. Semin. Thromb. Hemost. 2007, 33:534-539.
28. Simonis D., Fritzsche J., Alban S., Bendas G. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition. Biochemistry 2007, 46:6156-6164.
29. Borsig L., Wong R., Hynes R.O., Varki N.M., Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. U S A 2002, 99:2193-2198.
30. Borsig L., Wong R., Feramisco J., Nadeau D.R., Varki N.M., Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. U S A. 2001, 98:3352-3357.
31. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 1997, 36:245-319.
32. Jacob G.S., Kirmaier C., Abbas S.Z., Howard S.C., Steininger C.N., Welply J.K., Scudder P. Binding of Sialyl Lewis x to E-selectin as measured by fluorescence polarization. Biochemistry 1995, 34:1210-1217.
33. Wilkins P.P., McEver R.P., Cummings R.D. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J. Biol. Chem. 1996, 271:18732-18742.
34. Somers W.S., Tang J., Shaw G.D., Camphausen R.T. Insight into the molecular basis of leukocyte tethering and rolling as revealed by structures of P- and E-selectin bound to sLex and PSGL-1. Cell 2000, 103:467-479.
35. Enders S., Bernhard G., Zakrzewicz A., Tauber R. Inhibition of L-selectin binding by polyacrylamide-based conjugates under defined flow conditions. Biochim. Biophys. Acta 2007, 1770:1441-1449.
36. Vogel J., Bendas G., Bakowsky U., Hummel G., Schmidt R.R., Kettmann U., Rothe U. The role of glycolipids in mediating cell adhesion: a flow chamber study. Biochim. Biophys. Acta 1998, 1372:205-215.
37. Borthakur G., Cruz M.A., Dong J.F., McIntire L., Li F., Lopez J.A., Thiagarajan P. Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J. Thromb. Haemost. 2003, 1:1288-1295.
38. Galustian C., Childs R.A., Yuen C.T., Hasegawa A., Kiso M., Lubineau A., Shaw G., Feizi T. Valency dependent pattern of binding of human L-selectin towards sialyl and sulfated oligosaccharides of Lea and Lex types: relevance to anti-adhesion therapeutics. Biochemistry 1997, 36:5260-5266.